Literature DB >> 33264634

Extracellular vesicles derived from bone marrow mesenchymal stem cells enhance myelin maintenance after cortical injury in aged rhesus monkeys.

Veronica Go1, Deniz Sarikaya2, Yuxin Zhou3, Bethany G E Bowley3, Monica A Pessina3, Douglas L Rosene4, Zheng Gang Zhang5, Michael Chopp6, Seth P Finklestein7, Maria Medalla8, Benjamin Buller5, Tara L Moore8.   

Abstract

Cortical injury, such as stroke, causes neurotoxic cascades that lead to rapid death and/or damage to neurons and glia. Axonal and myelin damage in particular, are critical factors that lead to neuronal dysfunction and impair recovery of function after injury. These factors can be exacerbated in the aged brain where white matter damage is prevalent. Therapies that can ameliorate myelin damage and promote repair by targeting oligodendroglia, the cells that produce and maintain myelin, may facilitate recovery after injury, especially in the aged brain where these processes are already compromised. We previously reported that a novel therapeutic, Mesenchymal Stem Cell derived extracellular vesicles (MSC-EVs), administered intravenously at both 24 h and 14 days after cortical injury, reduced microgliosis (Go et al. 2019), reduced neuronal pathology (Medalla et al. 2020), and improved motor recovery (Moore et al. 2019) in aged female rhesus monkeys. Here, we evaluated the effect of MSC-EV treatment on changes in oligodendrocyte maturation and associated myelin markers in the sublesional white matter using immunohistochemistry, confocal microscopy, stereology, qRT-PCR, and ELISA. Compared to vehicle control monkeys, EV-treated monkeys showed a reduction in the density of damaged oligodendrocytes. Further, EV-treatment was associated with enhanced myelin maintenance, evidenced by upregulation of myelin-related genes and increases in actively myelinating oligodendrocytes in sublesional white matter. These changes in myelination correlate with the rate of motor recovery, suggesting that improved myelin maintenance facilitates this recovery. Overall, our results suggest that EVs act on oligodendrocytes to support myelination and improves functional recovery after injury in the aged brain. SIGNIFICANCE: We previously reported that EVs facilitate recovery of function after cortical injury in the aged monkey brain, while also reducing neuronal pathology (Medalla et al. 2020) and microgliosis (Go et al. 2019). However, the effect of injury and EVs on oligodendrocytes and myelination has not been characterized in the primate brain (Dewar et al. 1999; Sozmen et al. 2012; Zhang et al. 2013). In the present study, we assessed changes in myelination after cortical injury in aged monkeys. Our results show, for the first time, that MSC-EVs support recovery of function after cortical injury by enhancing myelin maintenance in the aged primate brain.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Cortical injury; Extracellular vesicles; Monkeys; Myelin; Non-human primates; Oligodendrocytes; Stroke; White matter

Mesh:

Year:  2020        PMID: 33264634      PMCID: PMC7946396          DOI: 10.1016/j.expneurol.2020.113540

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  62 in total

1.  Age changes in myelinated nerve fibers of the cingulate bundle and corpus callosum in the rhesus monkey.

Authors:  Michael P Bowley; Howard Cabral; Douglas L Rosene; Alan Peters
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

2.  Olig2-dependent developmental fate switch of NG2 cells.

Authors:  Xiaoqin Zhu; Hao Zuo; Brady J Maher; David R Serwanski; Joseph J LoTurco; Q Richard Lu; Akiko Nishiyama
Journal:  Development       Date:  2012-05-23       Impact factor: 6.868

Review 3.  Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.

Authors:  Donald G Phinney; Mark F Pittenger
Journal:  Stem Cells       Date:  2017-03-10       Impact factor: 6.277

Review 4.  Models that matter: white matter stroke models.

Authors:  Elif G Sozmen; Jason D Hinman; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

5.  Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.

Authors:  James A Duce; William Hollander; Rebecca Jaffe; Carmela R Abraham
Journal:  Neurobiol Aging       Date:  2005-06-29       Impact factor: 4.673

Review 6.  Repair of myelin disease: strategies and progress in animal models.

Authors:  I D Duncan; W E Grever; S C Zhang
Journal:  Mol Med Today       Date:  1997-12

Review 7.  Treatment of neural injury with marrow stromal cells.

Authors:  Michael Chopp; Yi Li
Journal:  Lancet Neurol       Date:  2002-06       Impact factor: 44.182

8.  Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

Authors:  Hideaki Yokoo; Sumihito Nobusawa; Hirohide Takebayashi; Kazuhiro Ikenaka; Koji Isoda; Makoto Kamiya; Atsushi Sasaki; Junko Hirato; Yoichi Nakazato
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 9.  Myelin damage and repair in pathologic CNS: challenges and prospects.

Authors:  Arsalan Alizadeh; Scott M Dyck; Soheila Karimi-Abdolrezaee
Journal:  Front Mol Neurosci       Date:  2015-07-27       Impact factor: 5.639

Review 10.  Activity-dependent central nervous system myelination throughout life.

Authors:  Omar de Faria; David G Gonsalvez; Madeline Nicholson; Junhua Xiao
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

View more
  3 in total

1.  Proficiency of Extracellular Vesicles From hiPSC-Derived Neural Stem Cells in Modulating Proinflammatory Human Microglia: Role of Pentraxin-3 and miRNA-21-5p.

Authors:  Raghavendra Upadhya; Leelavathi N Madhu; Shama Rao; Ashok K Shetty
Journal:  Front Mol Neurosci       Date:  2022-05-17       Impact factor: 6.261

Review 2.  Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke.

Authors:  Li Zhou; Huimin Zhu; Xue Bai; Jiagui Huang; Yue Chen; Jun Wen; Xuemei Li; Bowen Wu; Yongjun Tan; Mingfen Tian; Jiangxia Ren; Mengxia Li; Qin Yang
Journal:  Stem Cell Res Ther       Date:  2022-05-12       Impact factor: 8.079

Review 3.  Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke.

Authors:  Reed Berlet; Stefan Anthony; Beverly Brooks; Zhen-Jie Wang; Nadia Sadanandan; Alex Shear; Blaise Cozene; Bella Gonzales-Portillo; Blake Parsons; Felipe Esparza Salazar; Alma R Lezama Toledo; Germán Rivera Monroy; Joaquín Vega Gonzales-Portillo; Cesario V Borlongan
Journal:  Biomolecules       Date:  2021-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.